Corteva Inc. (C1TV34) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Corteva Inc. BRL 36.06, price BRL 101, upside -64.2%, quality 74 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Corteva Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 29, 2026.
How to read this chart
60‑month range R$51.06 – R$115.51 · fair‑value band R$33.77 – R$45.07 · the R$100.79 price screens above the R$36.06 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 29, 2026.
Follow Corteva in your weekly email
Every Wednesday you see whether Corteva is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms.
Show more
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
Stock analysis
Corteva Inc. (C1TV34) currently trades at R$100.79, while our model-based Fair Value estimate is R$36.06, 64.2% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of R$66.75 per share, and 0 of the 24 models we run sit above the R$100.79 price.
Bear case: the Dividend Discount group reads lowest at R$12.03, and 24 of the 24 models stay below the price. Evidence for this calculation is medium.
Scenario range: R$33.77 (bear) to R$45.07 (bull), the price of R$100.79 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 74/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Corteva Inc. reported revenue of $17.4B in FY2025 versus $15.7B in FY2021, a compound +2.7%/yr. Reported net income was $1.1B in FY2025, compounding −11.2%/yr from FY2021.
Key figures
Market cap R$284B (≈ $54.4B) · P/E ratio 42.0 · P/S ratio 2.64 · EPS (TTM) R$2.40 · Dividend yield 0.7% · Net margin 6.3% · Return on equity 5.1% · Return on assets (EBIT) 4.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 13% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 17% fair-value upside, at −64%, C1TV34 screens richer than that median.
Fair Value models
Bear R$33.77Fair Value R$36.06Bull R$45.07
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (R$1.27 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.67/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+2.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.9%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+0.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−0.5%
Dividend (yield on the price)0.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 14%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−18.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −20.0% a year for the price and +1.1% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (99 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 176 stocks
Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score74 · Top 25%
Fair Value upside−63.5% · Bottom 25%
Profitability
Return on equity (TTM)5.1% · Below median
Return on assets4.3% · Above median
Net margin (TTM)6.5% · Above median
Operating margin (TTM)23.7% · Top 25%
Growth and dividend
Revenue growth11.0% · Above median
Dividend yield (TTM)0.7% · Bottom 25%
Balance sheet
Debt / equity0.07× · Above median
Valuation Multiplesvs Agricultural Inputs median · lower = cheaper
P/E (TTM)42.0× · Priciest 25%
PEG1.38× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 22
FUTURE (revenue growth)55· sector 20
PAST (return on equity)21· sector 24
HEALTH (low debt)97· sector 97
DIVIDEND (yield)14· sector 43
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Corteva Inc. Fair Value". https://www.fairvalue-calculator.com/stock/C1TV34
Frequently asked questions
Is Corteva Inc. (C1TV34) overvalued or undervalued?
As of Sep 29, 2026, our model estimates a fair value of R$36.06 versus a price of R$100.79, about −64% upside (overvalued).
What is the fair value of C1TV34?
Our model-based fair value for Corteva Inc. is R$36.06 (as of Sep 29, 2026), built from audited fundamentals. The current price: R$100.79.
What is the quality score of C1TV34?
Corteva Inc. has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Corteva Inc. (C1TV34)?
Our model-based price target is the fair value of R$36.06 (as of Sep 29, 2026) from 24 valuation models. Cautious scenario R$33.77, optimistic scenario R$45.07. It is a calculation from audited fundamentals, not an analyst target.
What is the Corteva Inc. stock forecast for 2026?
Our models put fair value at R$36.06, about −64% upside versus a price of R$100.79 (overvalued). Cautious scenario R$33.77, optimistic scenario R$45.07. The calculation is refreshed regularly with new filings.
What is the revenue of Corteva Inc. (C1TV34)?
Corteva Inc. reported trailing-twelve-month revenue of about $17.9B (latest available figure, as of Sep 29, 2026).
Does Corteva Inc. pay a dividend?
Corteva Inc. currently shows a dividend yield of about 0.71% relative to its recent price (as of Sep 29, 2026).
What growth is priced into Corteva Inc. (C1TV34)?
For today's price to be fair in a discounted-cash-flow model, Corteva Inc. would have to grow free cash flow by -18.1 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.1 % per year. As of Sep 29, 2026.
What discount rate (WACC) does the fair value of C1TV34 use?
Our models discount Corteva Inc. at 10.9 %: a base by market capitalisation (large), damped by beta 0.56, country premium for Brazil. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Corteva Inc. that is -18.1 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has Corteva Inc. (C1TV34) delivered so far?
Over the past 5 years revenue at Corteva Inc. grew +4.1 % a year. The price currently implies -18.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Corteva Inc. (C1TV34) growing?
The median revenue growth in the sector is +8.0 % a year. That is the yardstick for the growth priced into Corteva Inc. (-18.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Corteva Inc. (C1TV34)?
The free-cash-flow yield on the price is 21.70 %: that much free cash flow Corteva Inc. produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Corteva Inc. (C1TV34)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Corteva Inc. it is R$36.06 per share (as of Sep 29, 2026), against a price of R$100.79. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Corteva Inc. stock overvalued or undervalued in 2026?
As of Sep 29, 2026, C1TV34 trades above its calculated fair value: price R$100.79, fair value R$36.06, a gap of about −64% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of C1TV34?
No. The price is what the market pays today (R$100.79); the fair value is what the company's own numbers justify (R$36.06). For Corteva Inc. the two are R$64.73 per share apart. That gap is exactly why we show both numbers side by side.
How much is Corteva Inc. worth?
The market values Corteva Inc. at about R$284B (market capitalisation, as of Sep 29, 2026). Per share that is R$100.79; our models calculate a fair value of R$36.06 per share.
What do the bullish and bearish scenarios say about C1TV34?
Our models span a range for Corteva Inc.: cautious scenario R$33.77, base R$36.06, optimistic R$45.07 per share (as of Sep 29, 2026, price R$100.79). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of C1TV34?
Corteva Inc. trades at a price-to-earnings ratio of 42.0 (as of Sep 29, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of R$36.06 is built from several models across several years. Other multiples: PEG 1.4.
What is the PEG ratio of C1TV34?
The PEG ratio of Corteva Inc. is 1.38 (P/E divided by earnings growth, as of Sep 29, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Corteva Inc. (C1TV34)?
Balance-sheet figures for Corteva Inc. (as of Sep 29, 2026): return on equity 5.1%, debt of 0.07 per unit of equity. They feed the Quality Score of 74/100, which measures business quality independently of the share price.
How far is C1TV34 from its 52-week high?
Corteva Inc. trades at R$100.79, about 13% below its 52-week high of R$115.51 and 26% above the low of R$79.75 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of R$36.06 is for.
Which stocks are comparable to Corteva Inc.?
From the same area (Basic Materials) we also value Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, SABIC Agri-Nutrients Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Corteva Inc. stock attractive at the current price?
The data as of Sep 29, 2026: price R$100.79, calculated fair value R$36.06 (−64%), Quality Score 74/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of C1TV34 calculated?
We run Corteva Inc. through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of R$36.06, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Corteva Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Corteva Inc. (C1TV34)?
The closing price on Oct 1, 2026 was R$100.79. Our model-based fair value is R$36.06, about −64% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Corteva Inc. right now?
A high-quality business (quality 74/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (R$45.07). The favourable scenario is already priced in.
Key figures of Corteva Inc.
How large is the market capitalisation of Corteva Inc. (C1TV34)?
The market capitalisation of Corteva Inc. is R$284B (≈ $54.4B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Corteva Inc. (C1TV34)?
The price-to-sales ratio of Corteva Inc. is 2.64 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Corteva Inc. (C1TV34)?
Earnings per share at Corteva Inc. are R$2.40 (price ÷ EPS = P/E 42.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Corteva Inc. (C1TV34)?
The dividend yield of Corteva Inc. is 0.7% (payout 30.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Corteva Inc. (C1TV34)?
The net margin of Corteva Inc. is 6.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Corteva Inc. (C1TV34)?
The return on equity (ROE) of Corteva Inc. is 5.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Corteva Inc. (C1TV34)?
On an EBIT basis the return on assets of Corteva Inc. is 4.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Corteva Inc. (C1TV34)?
The operating margin of Corteva Inc. is 23.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Corteva Inc. (C1TV34)?
Revenue at Corteva Inc. is growing +11.0% versus a year earlier (3y avg −0.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Corteva Inc. (C1TV34)?
Earnings per share at Corteva Inc. are growing +12.1% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Corteva Inc. in the live analysis
One click puts Corteva Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
